Moreover, TLR9-mediated responses may serve as a means to augment antibacterial immunity in MRSA pneumonia or empyema, and these data may facilitate move forward in the development of new treatment strategies against MRSA infection. Here, TLR9 is linked to Methicillin-Resistant Staphylococcus Aureus Pneumonia.